Chung-TsenHsuehMD
Oncology • Loma Linda, CAGastrointestinal Cancer, Head & Neck Cancer, Sarcoma
Professor of Medicine, Hematology/Oncology, Loma Linda University Health; Editor-in-Chief, Biomarker Research
Dr. Hsueh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11370 Anderson St
Suite 3650
Loma Linda, CA 92354Phone+1 909-558-2884Fax+1 909-558-2415
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1996 - 1999
University at BuffaloResidency, Internal Medicine, 1993 - 1996
State University of New York at BuffaloPh.D, Pharmacology, 1989 - 1993
Taipei Medical UniversityClass of 1986
Certifications & Licensure
CA State Medical License 2007 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2005
- Who’s Who in Medicine and Healthcare - Marquis Marquis, U.S.A., 2011
- Merit Award - American Society of Clinical Oncology American Society of Clinical Oncology, 1998
- Join now to see all
Clinical Trials
- S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
- Proton Therapy for Esophageal Cancer Start of enrollment: 2013 Feb 20
- Proton Therapy in the Treatment of Liver Metastases Start of enrollment: 2012 Aug 22
- Join now to see all
Publications & Presentations
PubMed
- 45 citationsNovel biomarkers for diagnosis, prognosis, targeted therapy and clinical trialsChung-Tsen Hsueh, Delong Liu, Hong Wang
Biomarker Research. 2013-01-16 - 80 citationsCombination antiangiogenic therapy and radiation in head and neck cancersHeng-Wei Hsu, Nathan R. Wall, Chung-Tsen Hsueh, Seungwon Kim, Robert L. Ferris
Oral Oncology. 2014-01-01 - 67 citationsMulticenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1...Michael J. Wagner, Megan Othus, Sandip Pravin Patel, Christopher W. Ryan, Ashish Sangal
Journal for Immunotherapy of Cancer. 2021-08-01
Press Mentions
Pancreatic cancer is an aggressive disease September 12th, 2021
Durable IO therapy responses in angiosarcomaSeptember 12th, 2021- Congratulations 1998-1999 AACR Research Fellows!September 12th, 2021
- Join now to see all
Professional Memberships
- Fellow
- Member
- Member
- Member
- Member
- National Cancer Institute InvestigatorMember
- Southwest Oncology Group InvestigatorMember
- Chinese American Hematologist and Oncologist NetworkMember
Other Languages
- Chinese (Mandarin)
External Links
- Loma Linda University Healthhttp://medical-center.lomalindahealth.org/provider/hsueh-chung
- Loma Linda Universityhttps://home.llu.edu/education/faculty/hsueh-chung-tsen/education
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
